Physical and psychological needs of patients dying from colo-rectal cancer

Maguire, Peter; Walsh, Sheila; Jeacock, Julie; Kingston, Reg
January 1999
Palliative Medicine;1999, Vol. 13 Issue 1, p45
Academic Journal
Determines terminal colo-rectal cancer patients' key physical complaints, main concerns and whether or not an effective disorder was present. Semistructured interview conducted by trained nurses; Patient characteristics; Physical symptoms; Psychiatric disorders in patients; General practitioners' assessments; Carer's concerns and psychiatric morbidity.


Related Articles

  • Disease can't stop Russo from giving his all on the court. Russo, Dan // Handball;Oct2007, Vol. 57 Issue 5, p32 

    The author presents a first person account of maintaining his avocation as a handball player while undergoing aggressive colon cancer treatment. He has had five surgeries and three years of chemotherapy, but has been able to continue playing at a satisfactory level despite an unavoidable loss of...

  • Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Schofield, Penelope; Stockler, M.; Zannino, D.; Tebbutt, N.; Price, T.; Simes, R.; Wong, N.; Pavlakis, N.; Ransom, D.; Moylan, E.; Underhill, C.; Wyld, D.; Burns, I.; Ward, R.; Wilcken, N.; Jefford, M.; Schofield, Penelope E; Stockler, M R; Tebbutt, N C; Price, T J // Supportive Care in Cancer;Jan2016, Vol. 24 Issue 1, p401 

    Purpose: Psychological responses to cancer are widely believed to affect survival. We investigated associations between hope, optimism, anxiety, depression, health utility and survival in patients starting first-line chemotherapy for metastatic colorectal cancer.Methods:...

  • Continuing Medical Education Questions: July 2011. DeVault, Kenneth R.; Carey, Emily; Hanouneh, Ibrahim; Kane, Saul; Navaneethan, Udayakumar // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1207 

    A quiz concerning colonoscopy of elderly patients with colorectal cancer is presented.

  • The Prognostic Significance of Chromosome Abnormalities in Colon Tumors. Lubs, Herbert A.; Kotler, Stuart // Annals of Internal Medicine;Aug67, Vol. 67 Issue 2, p328 

    Provides information on a study that examined the clinical-cytogenetic correlations in patients with colon tumors. Methodology of the study; Results and discussion on the study.

  • Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Monnet, E; Faivre, J; Raymond, L; Garau, I // British Journal of Cancer;10/1/99, Vol. 81 Issue 3, p463 

    Important differences have recently been highlighted between European countries in the survival of colorectal cancer patients. As data on stage at diagnosis were available for rectal cancers in three European population-based registries (Geneva Switzerland; Côte d'Or, France; Mallorca,...

  • A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Kabat, G. C.; Miller, A. B.; Jain, M.; Rohan, T. E. // British Journal of Cancer;12/3/2007, Vol. 97 Issue 11, p1600 

    A correction to the article "A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women" that was published in the previous issue is presented.

  • Letter to the Editor: Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation. Yin, Peihao; Qiu, Yanyan; Li, Qi // International Journal of Colorectal Disease;May2013, Vol. 28 Issue 5, p733 

    A letter to the editor is presented in response to the article "Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation," by Peihao Yin, Yanyan Qiu and Qi Li, published in the previous issue of the periodical.

  • QuickStats.  // MMWR: Morbidity & Mortality Weekly Report;3/27/2015, Vol. 64 Issue 11, p310 

    A chart is presented that shows the mortality rates of U.S. people with colorectal cancer from 1999 to 2013.

  • Ziv-aflibercept yields encouraging results in metastatic colorectal cancer.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p26 

    The article reports on a study by Doctor Eric Van Cutsem, head of digestive oncology and professor of medicine at University Hospital Gasthuisberg in Leuven, Belgium, stating that the addition of ziv-aflibercept to infusional FOLFIRI improved survival in metastatic colorectal cancer patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics